NCT07156227 2026-03-18Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell CarcinomaNational Cancer Institute (NCI)Phase 1 Not yet recruiting39 enrolled